Avelumab and cetuximab in combination with FOLFOX in patients with previously untreated metastatic colorectal cancer (MCRC): Final results of the phase II AVETUX trial (AIO-KRK-0216).
暂无分享，去创建一个
C. Bokemeyer | A. Hinke | A. Stein | S. Al-Batran | E. Goekkurt | J. Riera-Knorrenschild | T. Ettrich | M. Binder | S. Lorenzen | R. Depenbusch | S. Doerfel | M. Karthaus | U. Pelzer | D. Simnica | L. Waberer | S. Hegewisch‐Becker | Steffen Doerfel